Back
CRISPR Therapeutics AG Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
56
CRSP
CRISPR Therapeutics AG
Last Price:
$54.95
Seasonality Move:
-3%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atCRISPR Therapeutics AG Stock Forecast
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 31.1% based on the past 9 years of stock performance.
-
CRISPR Therapeutics AG has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is CRISPR Therapeutics AG Stock Undervalued?The current CRISPR Therapeutics AG [CRSP] share price is $56.40. The Score for CRSP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
CRSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 31.1% based on the past 9 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Buy
56
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG overpriced?
-
CRISPR Therapeutics AG has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
78.48
52-Week Low:
30.04
Prediction Charts
Market Cap:
5.4B
Price in USD:
56.40
Volume:
1.5M
Beta:
2.05
Technical Analysis
SMA50:
55.87
SMA100:
58.83
SMA200:
51.83
52-Wk Change:
36.59%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?Yes, CRISPR Therapeutics AG is a publicly traded company.
-
What is the CRISPR Therapeutics AG stock quote today?The CRISPR Therapeutics AG stock price is 56.40 USD today.
-
How to buy CRISPR Therapeutics AG stock online?You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-17 | 55.74 | 54.74 | 58.00 | 54.60 |
| Dec-18 | 54.90 | 54.84 | 57.03 | 54.77 |
| Dec-19 | 55.35 | 55.86 | 56.68 | 55.00 |
| Dec-22 | 56.02 | 57.91 | 59.18 | 54.50 |
| Dec-23 | 57.10 | 56.46 | 57.24 | 55.81 |
| Dec-24 | 56.45 | 56.71 | 56.83 | 55.21 |
| Dec-26 | 56.48 | 55.08 | 56.54 | 53.76 |
| Dec-29 | 54.59 | 53.97 | 55.41 | 53.80 |
| Dec-30 | 54.06 | 53.19 | 54.12 | 52.98 |
| Dec-31 | 53.13 | 52.44 | 53.46 | 52.35 |
| Jan-5 | 53.82 | 55.15 | 55.52 | 53.73 |
| Jan-6 | 55.13 | 58.19 | 60.73 | 54.90 |
| Jan-7 | 58.72 | 57.99 | 59.89 | 57.30 |
| Jan-8 | 57.75 | 56.40 | 57.75 | 56.03 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $0.40 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.